{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:27:54Z","timestamp":1761560874563},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.ijantimicag.2003.09.002","type":"journal-article","created":{"date-parts":[[2004,3,6]],"date-time":"2004-03-06T10:39:45Z","timestamp":1078569585000},"page":"41-53","source":"Crossref","is-referenced-by-count":24,"special_numbering":"S1","title":["Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections"],"prefix":"10.1016","volume":"23","author":[{"given":"K.G.","family":"Naber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bartnicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hanus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Milutinovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"van Belle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sch\u00f6nwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ankel-Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0924-8579(94)90019-1","article-title":"Quinolones in the treatment of complicated urinary tract infection","volume":"4","author":"Graninger","year":"1994","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB2","unstructured":"Mandell GL, Douglas RG, Bennet JE, Principles and Practice of Infectious Diseases, 3rd ed. New York: Churchill Livingston; 1990."},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF01710009","article-title":"Urinary tract infections in the 90s: pathogenesis and management","volume":"20","author":"Andriole","year":"1992","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9343(92)90312-Y","article-title":"Urinary tract infections","volume":"92","author":"Neu","year":"1992","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF01704364","article-title":"Standard of therapy for urinary infections in adults","volume":"20","author":"Ronald","year":"1992","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF01716031","article-title":"Urinary tract infection in men\u2014state of the art","volume":"22","author":"Schaeffer","year":"1994","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000473671","article-title":"Complicated urinary tract infections","volume":"19","author":"Conrad","year":"1991","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF01704358","article-title":"Criteria for the diagnosis of urinary tract infection and for the assessment of therapeutic effectiveness","volume":"20","author":"Stamm","year":"1994","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB9","first-page":"12","article-title":"Mechanisms of action and resistance to ciprofloxacin","volume":"82","author":"Hooper","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00003495-200262010-00007","article-title":"Gatifloxacin\u2014a review of its use in the management of bacterial infections","volume":"62","author":"Perry","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB11","unstructured":"Deutsches Institut f\u00fcr Normung 58940. Medical microbiology\u2014susceptibility testing of pathogens to antimicrobial agents. Part 3. Agar diffusion test. Data for the interpretation of inhibition diameters. Berlin: Beuth; 1996."},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB12","unstructured":"National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility tests. Approved Standard M2-A5. Wayne, PA: NCCLS; 1996."},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB13","unstructured":"Grimm H. In vitro studies with AM1155 a new 6-fluoroquinolone. Interpretive criteria for the disk susceptibility testing. Presented at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, 15 September, New Orleans, LA; 1996."},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB14","unstructured":"Physician\u2019s Desk Reference (PDR), 53rd ed. Montvale, NJ: Medical Economics Company Inc.; 1999. p. 641."},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB15","unstructured":"Deutsches Institut f\u00fcr Normung 58940. Medical microbiology\u2014susceptibility testing of pathogens to antimicrobial agents. Part 4. Evaluation classes of the minimum inhibitory concentration. MIC breakpoints of antibacterial agents. Berlin: Beuth; 1995."},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB16","unstructured":"National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. Wayne, PA: NCCLS; 1995."},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB17","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/sim.4780091208","article-title":"Test statistics and a sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference of non-unity relative risk","volume":"9","author":"Farrington","year":"1990","journal-title":"Stats. Med."},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB18","unstructured":"Hollander M, Woolfe DA. Nonparametric Statistical Methods. New York: Wiley; 1973."},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB19","unstructured":"Breslow NE, Day NE. Statistical methods in cancer research, vol. 1. Int. Lyon: Agency for Research on Cancer; 1980."},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB20","unstructured":"Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE, editors (with modification by a European Working Party (Norrby R)). General guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infection. In: Beam TR, Gilbert DN, Kunin CM, editors. European Guidelines for the Clinical Evaluation of Anti-infective Drug Products. European Society of Clinical Microbiology and Infectious Diseases; 1993. p. 294\u2013310."},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB21","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0022-5347(01)64252-6","article-title":"Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections","volume":"158","author":"Frankenschmidt","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/j.ijantimicag.2003.09.002_BIB22","unstructured":"Goldman I, Bennett JC. Cecil Textbook of Medicine, 21st ed. Philadelphia: WB Saunders; 2000. p. 616."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903003364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903003364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T20:20:29Z","timestamp":1550175629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857903003364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":22,"alternative-id":["S0924857903003364"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2003.09.002","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}